EUVIMEDEUVIMED entdecken
Crossref

Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer

Yajun Xu iD, Jianlin Lv, Ya Liu, Jincheng Du, Chuwen Luo, Ying Wang, Linlin Liu, Kazuo Sakurai iD, Zhaohui Tang iD, Xuesi Chen iD

Nano Letters · 08.01.2025 · 25 (1) · 504-513

DOI: 10.1021/acs.nanolett.4c05355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 16.12.2024. Verfasst von Yajun Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Lung Neoplasms, Breast Neoplasms, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transforming growth factor β (TGF-β) signaling pathway exerts a dual role in oncogenesis, acting as a suppressor in healthy and early stage neoplastic tissues while promoting malignancy and metastasis in advanced cancers. Tumor hemorrhage further exacerbates TGF-β-mediated metastasis by up-regulating its expression. Here, a coagulation-targeting peptide (A15)-decorated TGF-β inhibitor nanomedicine (A15-LY-NPs) was developed. The tumor colonization assays showed that the nanomedicine reduced 4T1-luc cell colonization in normal tissues. When combined with a vascular disrupting agent, A15-LY-NPs demonstrated three times greater drug accumulation in the tumor at 24 h compared to the control and showed a 93.7% tumor suppression rate in 4T1 tumors initiated at ∼500 mm3, significantly attenuating metastatic spread to the lungs and liver. This study presents an innovative approach for the precise and efficient delivery of TGF-β inhibitors to tumors, offering the potential to augment the efficacy of cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor betaLung NeoplasmsBreast NeoplasmsSignal TransductionNanomedicineAnimalsFemaleMiceCell Line, TumorHumansBlood CoagulationPeptidesAntineoplastic AgentsNanoparticlesMice, Inbred BALB C

Stichwörter der Autor:innen

TGF-β inhibitorsactive targetingcoagulationtargeted drug deliverytumor metastasis inhibitionvascular disrupting agent

Substanzen

Transforming Growth Factor betaPeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China.
  • Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, China.
  • Department of Breast Surgery, The Second Hospital of Jilin University, Changchun 130041, China.
  • Department of Chemistry and Biochemistry, The University of Kitakyushu, 1-1 Hibikino, Kitakyushu 808-0135, Japan.

ORCID-Profile: Yajun Xu, Kazuo Sakurai, Zhaohui Tang, Xuesi Chen

Förderung

  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Xu, Y., Lv, J., Liu, Y., Du, J., Luo, C., Wang, Y., Liu, L., Sakurai, K., Tang, Z., & Chen, X. (2025). Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer. Nano Letters, 25(1), 504-513. https://doi.org/10.1021/acs.nanolett.4c05355

Vancouver

Xu Y, Lv J, Liu Y, Du J, Luo C, Wang Y, et al. Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer. Nano Letters. 2025;25(1):504-513. doi:10.1021/acs.nanolett.4c05355

BibTeX
@article{Xu2025,
  author = {Xu, Yajun and Lv, Jianlin and Liu, Ya and Du, Jincheng and Luo, Chuwen and Wang, Ying and Liu, Linlin and Sakurai, Kazuo and Tang, Zhaohui and Chen, Xuesi},
  title = {Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer},
  journal = {Nano Letters},
  year = {2025},
  volume = {25},
  number = {1},
  pages = {504--513},
  doi = {10.1021/acs.nanolett.4c05355}
}
Kostenlos starten →